Health & Environmental Research Online (HERO)


Print Feedback Export to File
4220319 
Journal Article 
Relationship between peroxisome proliferator-activated receptor alpha activity and cellular concentration of 14 perfluoroalkyl substances in HepG2 cells 
Rosenmai, AK; Ahrens, L; le Godec, T; Lundqvist, J; Oskarsson, A 
2018 
Yes 
Journal of Applied Toxicology
ISSN: 0260-437X
EISSN: 1099-1263 
John Wiley and Sons Ltd 
HOBOKEN 
38 
219-226 
English 
Peroxisome proliferator-activated receptor alpha (PPARα) is a molecular target for perfluoroalkyl substances (PFASs). Little is known about the cellular uptake of PFASs and how it affects the PPARα activity. We investigated the relationship between PPARα activity and cellular concentration in HepG2 cells of 14 PFASs, including perfluoroalkyl carboxylates (PFCAs), perfluoroalkyl sulfonates and perfluorooctane sulfonamide (FOSA). Cellular concentrations were determined by high-performance liquid chromatography-tandem mass spectrometry and PPARα activity was determined in transiently transfected cells by reporter gene assay. Cellular uptake of the PFASs was low (0.04-4.1%) with absolute cellular concentrations in the range 4-2500 ng mg-1 protein. Cellular concentration of PFCAs increased with perfluorocarbon chain length up to perfluorododecanoate. PPARα activity of PFCAs increased with chain length up to perfluorooctanoate. The maximum induction of PPARα activity was similar for short-chain (perfluorobutanoate and perfluoropentanoate) and long-chain PFCAs (perfluorododecanoate and perfluorotetradecanoate) (approximately twofold). However, PPARα activities were induced at lower cellular concentrations for the short-chain homologs compared to the long-chain homologs. Perfluorohexanoate, perfluoroheptanoate, perfluorooctanoate, perfluorononanoate (PFNA) and perfluorodecanoate induced PPARα activities >2.5-fold compared to controls. The concentration-response relationships were positive for all the tested compounds, except perfluorooctane sulfonate PFOS and FOSA, and were compound-specific, as demonstrated by differences in the estimated slopes. The relationships were steeper for PFCAs with chain lengths up to and including PFNA than for the other studied PFASs. To our knowledge, this is the first report establishing relationships between PPARα activity and cellular concentration of a broad range of PFASs. 
cellular concentration; perfluoroalkane sulfonamide; perfluoroalkyl carboxylates; perfluoroalkyl sulfonates; peroxisome proliferator-activated receptor alpha; PPAR 
PFAS
• Additional PFAS (formerly XAgency)
     Literature Search November 2019
          Other Sources
               TEDX
     Screened Studies
          Supplemental
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          PubMed
          Web of Science
          Other Sources
               PFAS TOX Database
     Screened Studies
          Supplemental
     Perfluorooctane
• PFAS 150
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
          Other sources
               PFAS TOX Database
     Not prioritized for screening
     Perfluorononanoic acid
     Perfluorooctane
     Perfluorooctanesulfonamide
     Perfluorooctanesulfonamide sodium salt (1:1)
     Perfluorooctanesulfonic acid
     Perfluorooctanoic acid
• PFBA
     Literature Search
          Pubmed
          WOS
     Literature Search Update 5/2019
          WOS
     Scopus: April 2021
     June 2022 Pelch Database
• PFDA
     Literature Search
          Pubmed
          WOS
     Literature Search Update 5/2019
          WOS
     Scopus: April 2021
     Title and Abstract Screening
          Full Text Screening
          Tagged as Supplemental
               Mechanistic or MOA
     June 2022 Pelch Database
     Literature Searches (through April 2023 update and post-public comment/peer review)a    
          Other
               Published PFAS SEMs
          Title & Abstract Screening
               Tagged as Supplemental
                    Full Text Screening
                    In vivo MOA, including non-PECO exposure route
                    In vitro and in silico models
• PFHpA
     Literature Search Update 2017-2019
          PubMed
          WOS
• PFHxA
     LitSearch Update: February 2018
          PubMed
          WoS
          Term Set 2: Initial Search
               PubMed
               WoS
     Literature Search
          Pubmed
          WOS
     Scopus: April 2021
     Title and Abstract Screening
          Full Text Screening
          Tagged as Supplemental
     Results pulled from Pelch database May 2022
     HAWC
• PFHxS
     Database searches
          Pelch PFAS SEM
     Supplemental
          TiAb
          In vitro or in silico studies (non-genotoxicity)
     Literature Search Update April 2023
          Supplemental
               In vitro in silico (non-genotoxicity)
• PFNA
     Litsearch Update 2017-2018
          PFAS Untag
     PFNA Literature Search pre-2019
          WOS
     Literature Search
          Pubmed
          Toxline
          WOS
     PFNA May 2019 Update
          Pubmed
          Toxnet
          Web of Science
     Title and Abstract Screening
          Full Text Screening
          Tagged as Supplemental
               Mechanistic or MOA
     June 2022 Pelch Database
• PFOA (335-67-1) and PFOS (1763-23-1)
     Screening Results
          In vivo animal studies
               Liver tox
          In vitro/ex vivo/in silico
     Literature Search Update (2013-2019)
          PubMed
          WOS